securities fraud

Class action lawsuit filed against $VTGN alleges securities fraud over misleading statements about fasedienol drug candidate and PALISADE-3 clinical trial data.

Class action filed against $PMI alleging securities fraud, false promotion, and insider share dumping via offshore accounts. Investors have until April 2026 to join.

Soleno Therapeutics faces class action lawsuit alleging failure to disclose safety concerns about DCCR drug candidate from clinical trials.

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about CELLECTRA device manufacturing and INO-3107 FDA submission timeline between October 2023 and December 2025.

Class action lawsuit filed against Kyndryl Holdings for alleged securities fraud, false financial disclosures, and internal control failures. Lead plaintiff deadline set for April 13, 2026.

Paysafe faces securities fraud class action over undisclosed high-risk merchant exposure and understated credit reserves. Investors have until April 7, 2026 to join.

Class action lawsuit filed against $CWH alleging false statements about inventory management capabilities, claiming misleading public disclosures harmed shareholders.

Schall Law Firm seeks lead plaintiffs for securities fraud lawsuit against Richtech Robotics ($RR) over alleged false Microsoft partnership claims.

Paysafe ($PSFE) faces class action lawsuit alleging securities fraud over hidden credit exposure and missed fiscal 2025 guidance. Investors have until April 7, 2026 to join.

DJS Law Group filed class action against $RR for securities violations, alleging false Microsoft partnership statements during January 27-29, 2026 period.

Ultragenyx Pharmaceutical's stock plunged 42% after failing to disclose setrusumab Phase 3 trial failure, triggering securities litigation with April 6, 2026 lead plaintiff deadline.

Rosen Law Firm investigates KDDI for allegedly misleading investors. Stock fell 11.4% after company postponed earnings disclosure due to internal investigation.

Nidec stock plunges 22.7% after announcing China accounting probe; law firms investigating securities fraud claims for affected investors.

Hub Group discloses accounting error understating costs, triggering 18.3% stock plunge and securities litigation investigation.

Kyndryl Holdings faces securities class action over undisclosed internal control weaknesses. Stock plunged 55% after February 2026 disclosure; lead plaintiff deadline set for April 13.

Enphase Energy faces class action lawsuit over alleged material misstatements regarding inventory management and tax credit impacts. Lead plaintiff deadline set for April 20, 2026.

$CORT stock plummets 50% after FDA rejects lead drug relacorilant; class action targets alleged disclosure failures with lead plaintiff deadline April 21, 2026.

Navan investors face April 24, 2026 deadline to file lead plaintiff applications in class action over undisclosed $95M sales/marketing expense surge in Q3 2025.

Soleno Therapeutics faces class action lawsuit alleging material safety concerns about DCCR drug were hidden from investors. Lead plaintiff deadline is May 5, 2026.

BellRing Brands faces securities class action alleging material disclosure failures from November 2024–August 2025, with stock declines of 19% and 33% following disappointing guidance.